** Shares of Glenmark Pharmaceuticals GLEN.NS up ~4% to 1350.5 rupees
** Co settles remaining antitrust and consumer protection lawsuits with three plaintiffs in connection with generic cholesterol drug Zetia
** Plaintiffs include Humana HUM.N, Centene Corp CNC.N
and Kaiser Foundation Health Plan [RIC:RIC:KISERF.UL]
** Under terms of $7 mln settlement, Glenmark denies allegations by plaintiffs, concedes no liability
** Including session's gains, GLEN shares up 48.3% in the last 12 months
(Reporting by Ananta Agarwal in Bengaluru)
((Ananta.Agarwal@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.